Pear Therapeutics, Inc. (PEAR) SEC Filing 8-K Material Event for the period ending Monday, March 28, 2022

Pear Therapeutics, Inc.

CIK: 1835567 Ticker: PEAR

View differences made from one to another to evaluate Pear Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pear Therapeutics, Inc..


Assess how Pear Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pear Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Pear Therapeutics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: PEAR
CIK: 1835567
Form Type: 8-K Corporate News
Accession Number: 0001835567-22-000005
Submitted to the SEC: Mon Mar 28 2022 4:05:49 PM EST
Accepted by the SEC: Mon Mar 28 2022
Period: Monday, March 28, 2022
Industry: Health Services
  1. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: